Alivus Life Sciences Ltd

NSE: ALIVUS · BSE: 543322 · Pharmaceuticals & Biotechnology · 34 announcements

Share price: ₹1,454.90
Market cap: ₹17,891 Cr
Revenue (annual): ₹2,552 Cr
Net profit (annual): ₹564.5 Cr
P/E (TTM): 26.7×Sector 43.8×
Promoter holding: 74.85%-0.02% QoQ
FII holding: 5.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 7 Financial Results 5 Results Update 3 Employee Stock Options 3 Board Meeting Date 3 Other Announcement 2 Merger & Restructuring 2 Annual General Meeting 2 Acquisition 2 Promoter Selling 1 Legal & Regulatory 1 Debt & Borrowing 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

7 Nov 2026 15:18 IST BSE

Promoter Selling

Alivus Life Sciences Promoter Selling

Nirma Limited, a promoter of Alivus Life Sciences, sold 36,80,000 shares (2.99%) in the open market on 6 November 2026. Promoter holding falls from 74.73% to 71.74%.

Open announcement → Read the filing ↗